Adaptive Biotechnologies(ADPT) - 2024 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2024 ADAPTIVE BIOTECHNOLOGIES CORPORATION (Exact name of Registrant as Specified in Its Charter) Washington 001-38957 27-0907024 (State or Other Jurisdiction (IRS Employer of Incorporation) (Commission File Number) Identification No.) 1165 Eastlake Avenue East Seattle, Washington 98109 ...